🔎 Trials Near Me

Hem › Crohns sjukdom › Missouri › St. Louis

Kliniska studier för Crohns sjukdom i St. Louis, MO

19 studier för Crohns sjukdom söker deltagare vid platser i och runt St. Louis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekryterarFas 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RekryterarFas 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • och 1 fler
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • Washington University School of Medicine ( Site 5058), St Louis
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekryterarFas 4
  • SSM Health Medical Group, Bridgeton · 15 mi bort
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekryterarFas 2
  • Washington University /ID# 266938, St Louis
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekryterarFas 3
  • Washington University School of Medicine, St Louis
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RekryterarFas 3
  • Washington University School of Medicine, St Louis
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RekryterarFas 2
  • KAD Clinical Research, St Louis
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi bort
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekryterarFas 2
  • KAD Clinical Research, St Louis
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekryterarFas 4
  • Washington University School of Medicine, St Louis
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

RekryterarFas 2
  • Washington University, St. Louis, St Louis
Ålder 18 till 75 · Alla kön · Uppdaterad 1 sep. 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

RekryterarFas 2
  • Washington University School of Medicine, St Louis
Ålder 18 till 80 · Alla kön · Uppdaterad 5 juni 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

RekryterarFas 2
  • Investigational Site Number: 8400013, St Louis
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekryterarFas 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi bort
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

RekryterarFas 1/2
  • Washington University in St. Louis, St Louis
Ålder 18 till 65 · Alla kön · Uppdaterad 10 dec. 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

RekryterarObservationsstudie
  • Washington University in St Louis School of Medicine, St Louis
Ålder 18 och äldre · Alla kön · Uppdaterad 12 nov. 2025 · NCT06670638

Crohns sjukdom-studier i andra städer

Andra studier i St. Louis

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.